Log in using OpenID

Global Non-melanoma Skin Cancer Market 2014-2018

Big Market Research “Global Non-melanoma Skin Cancer Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @
Global Non-melanoma Skin Cancer Market 2014-2018
Market , Share, Size, Trends, Analysis, Demand & Forecast to
Report Description:
About Non-melanoma Skin Cancer
Non-melanoma skin cancer is one of the most common types of cancer in the world. It
develops in the upper layers of the skin, but not in melanocytes. There are two types of nonmelanoma skin cancer: BCC, which starts in the basal cells, and SCC, which starts in the
squamous cells. BCC usually develops in the areas such as the head and neck, whereas SCC
starts in the face, ears, neck, lips, and backs of the hands.
These can also grow in wounds or chronic skin sores. Non-melanoma skin cancer is caused by
unprotected and excessive exposure to UV radiation. It affects men more than women. It can
be cured effectively if it is detected early. Treatment for non-melanoma skin cancer includes
surgery, laser therapy, cryotherapy, creams, radiotherapy, chemotherapy, and PDT.
The Global Non-melanoma Skin Cancer market to grow at a CAGR of 27.93 percent over the
period 2013-2018.
Read more details at:
Report Description:
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Non-melanoma
Skin Cancer market for the period 2014-2018. To calculate the market size, the report considers
the revenue generated from the following segments:
• Chemotherapy, which includes drugs used in the treatment of SCC, BCC, and actinic keratosis
• Non-invasive Treatments, which include PDT, radiotherapy, cryotherapy, and laser therapy
The Global Non-melanoma Skin Cancer Market 2014-2018, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the Americas and,
the EMEA and the APAC region; and its growth prospects in the coming years. The report also
includes a discussion of the key vendors operating in this market.
Key Vendors
• Elekta AB
• F. Hoffmann-la Roche Ltd.
• iCAD Inc.
• Meda AB
• Valeant Pharmaceuticals Inc.
• Varian Medical Systems Inc.
Key Regions:
Other Prominent Vendors
• Aqua Pharmaceuticals LLC
• Almirall SA
• Biofrontera AG
• Boehringer Ingelheim GmbH
• Bristol Myers Squibb Co.
• Cannabis Science Inc.
• Cellceutix Corp.
• Eli Lilly and Co.
• Galderma SA
• IRX Therapeutics Inc.
• LEO Pharma A/S
• Merck & Co. Inc.
• Moberg Pharma AB
Key Regions:
Market Driver
• Increasing Incidence of Non-melanoma Skin Cancer
• For a full, detailed list, view our report.
Market Challenge
• Availability of Alternative Treatments
• For a full, detailed list, view our report.
Market Trend
• Emergence of Combination Therapies
• For a full, detailed list, view our report.
Key Regions:
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
About report :
Visit us at :
Stay With Us:
TELEPHONE: + 1-800-910-6452
[email protected]
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Report inappropriate content